Miettinen H E, Gylling H, Miettinen T A, Viikari J, Paulin L, Kontula K
Institute of Biotechnology, University of Helsinki, Finland.
Arterioscler Thromb Vasc Biol. 1997 Jan;17(1):83-90. doi: 10.1161/01.atv.17.1.83.
We have identified a large kindred with severe serum HDL cholesterol deficiency. The proband, a 65-year-old woman, had greatly diminished concentrations of serum HDL cholesterol (0.19 mmol/L) and apolipoprotein (apo) A-I (21.9 mg/dL). HDL cholesterol and apo A-I levels were similarly reduced in all affected family members, while apo A-II levels were about half of those in the nonaffected family members. Pedigree analysis suggested a dominant inheritance pattern of the phenotype. Sequence analysis of the exons and exon-intron boundaries of the apo A-I gene revealed heterozygosity for a single T-to-G point mutation substituting arginine for leucine at residue 159 of the mature apo A-I protein (apo A-IFin). The T-to-G substitution destroys an Fsp I cleavage site, permitting direct polymerase chain reaction/restriction enzyme analysis of the mutation. All the affected family members were shown to be heterozygous for the apo A-IFin mutation. Isoelectric focusing revealed the presence of the mutant apo A-IFin protein in both serum and HDL of the affected subjects. Functional consequences of the mutation were examined by expressing the mutated and wild-type apo A-I cDNAs in COS-7 cells. The mutant apo A-I mRNA had a size similar to that of the normal mRNA, and both mutant and wild-type apo A-I proteins were secreted into the cell media. In vivo kinetic studies of apo A-I revealed increased catabolism in affected subjects. In conclusion, we describe a novel point mutation of the apo A-I gene, apo A-IFin, causing a dominantly negative phenotype as regards serum HDL levels, possibly due to increased catabolism of apo A-I.
我们鉴定出一个患有严重血清高密度脂蛋白(HDL)胆固醇缺乏症的大家族。先证者是一名65岁女性,其血清HDL胆固醇浓度(0.19 mmol/L)和载脂蛋白(apo)A-I(21.9 mg/dL)大幅降低。所有受影响家庭成员的HDL胆固醇和apo A-I水平均同样降低,而apo A-II水平约为未受影响家庭成员的一半。系谱分析表明该表型呈显性遗传模式。对apo A-I基因的外显子和外显子-内含子边界进行序列分析,发现成熟apo A-I蛋白(apo A-IFin)第159位残基处发生单个T到G的点突变,导致精氨酸替代亮氨酸,呈现杂合状态。T到G的替换破坏了一个Fsp I切割位点,使得能够直接通过聚合酶链反应/限制酶分析该突变。所有受影响家庭成员均显示为apo A-IFin突变的杂合子。等电聚焦显示受影响受试者的血清和HDL中均存在突变的apo A-IFin蛋白。通过在COS-7细胞中表达突变型和野生型apo A-I cDNA来检测该突变的功能后果。突变型apo A-I mRNA的大小与正常mRNA相似,突变型和野生型apo A-I蛋白均分泌到细胞培养基中。对apo A-I的体内动力学研究表明,受影响受试者的分解代谢增加。总之,我们描述了一种apo A-I基因的新型点突变,即apo A-IFin,它在血清HDL水平方面导致显性负性表型,可能是由于apo A-I的分解代谢增加所致。